Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial updates on safety, pharmacokinetics, and efficacy of an antithrombin III concentrate for antithrombin III deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antithrombin Iii Deficiency

Drugs mentioned

• ATIII Concentrate (antithrombin III concentrate)

Snippet

Sponsor: Grifols Biologicals, LLC | Conditions: Antithrombin III Deficiency | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING